Clostridium Butyricum: A Butyrate-Producing Probiotic
Clostridium Butyricum has one of the longer commercial track records of any probiotic strain, sold in Japan for close to a century for digestive complaints. Its more recent metabolic research is newer and considerably less settled — worth keeping the two histories separate.
- Botanical name
- Clostridium butyricum (bacterial strain, not a plant)
- Part used
- Live/spore-form bacterial culture
What it is
Clostridium butyricum is a spore-forming bacterium — a genuinely different category of probiotic from the more familiar Lactobacillus and Bifidobacterium species, because its spore form survives stomach acid more reliably without needing special coating. It has been sold as a commercial probiotic in Japan since the early twentieth century, most notably in a long-running product called Miyarisan, and has a correspondingly long safety track record for a probiotic strain.
Despite the name, it is a distinct species from Clostridium botulinum (the bacterium responsible for botulism) and Clostridioides difficile — sharing a genus with an organism does not mean sharing its properties, and C. butyricum has been safely consumed by millions of people over decades.
The butyrate mechanism, and what research shows
C. butyricum produces butyrate, a short-chain fatty acid that is the primary fuel source for the cells lining the colon (colonocytes) and plays a role in maintaining gut-barrier integrity. Butyrate production is a genuinely well-established area of microbiome science — it is not a fringe claim.
The bulk of the clinical research on this specific strain, mostly from Japan and China, has examined digestive outcomes: antibiotic-associated diarrhea, irritable bowel symptoms, and gut-barrier markers. More recent research has begun examining metabolic markers — blood glucose handling and inflammatory markers linked to metabolic syndrome — but this thread is newer, smaller, and has not yet produced the kind of large, independently replicated trials that would establish a reliable weight-management effect.
A practical note on the spore form: because it survives stomach acid without needing an enteric coating, it is one of the more heat-stable and shelf-stable probiotic species available, which is part of why it became commercially viable in capsule form decades before more fragile species did — a genuine practical advantage independent of any specific health claim.
Safety
What to check before taking it
- Severely weakened immune system. Rare cases of probiotic-associated bloodstream infection have been documented in critically ill or severely immunocompromised patients across probiotic species generally; speak to a doctor first if this applies to you.
- Currently on antibiotics. Standard practice is to separate probiotic and antibiotic dosing by a couple of hours, since antibiotics can reduce the live culture’s viability.
- Central venous catheter. The same rare bloodstream-infection caution applies more directly in this situation.
Outside of these specific situations, C. butyricum has one of the better-established safety records of any probiotic strain, reflecting its long commercial history. The research is searchable on PubMed.
How to read this guide
This page describes a plant and what has been studied about it. It is not advice about whether you personally should take anything. Dietary supplements are not medicines. They are not intended to diagnose, treat, cure or prevent any disease. Information on this page is for general education and does not replace advice from a doctor, pharmacist or other qualified health professional.
Talk to your doctor before starting any supplement if you take prescription medication, have a diagnosed condition, or are scheduled for surgery.